Strengthening global commitment to eliminating cervical cancer: What lessons from the past can we apply to the future?

This is the authors' abstract. We don't add key points for this paper.

85% of women diagnosed with cervical cancer live in low-and middle-income countries and the striking differences in access to vaccines, screening tests, diagnostic equipment and treatment between high-and low-income countries cannot be ignored.